Medincell

Medincell is a French pharmaceutical company committed to creating better medicines for all. They focus on developing long-acting injectable treatments based on their proprietary BEPO® technology, which allows for controlled and sustained release of drugs over days, weeks, or even months. This approach addresses key challenges in healthcare, including improving treatment adherence, enhancing accessibility, and minimizing environmental impact.

Medincell's innovative product candidates, developed both in-house and in collaboration with leading pharmaceutical companies and NGOs, target critical medical challenges. They are driven by a vision of empowering people, driving growth, and fostering a thriving workplace environment. Their commitment to responsible company practices is evident in their emphasis on employee share ownership, diversity, and ethical business conduct, all while striving to make a difference in global health.

Medincell embraces a modern approach to work-life balance by providing employees with flexible working hours and the option for remote work. This enables employees to have the freedom to perform at their best, wherever they are.

Medincell provides a comprehensive benefits package to its employees, including a competitive salary with regular reviews, performance-based bonuses and profit-sharing plans, substantial health and protection insurance benefits, annual commuting subsidies, a supportive childcare program, daily lunch vouchers, and a state-of-the-art workspace. Additionally, they promote employee share ownership, allowing all permanent members to become shareholders, and offer a flexible work environment with options for remote work. Their well-being program includes on-site sport coaching, yoga, and pilates sessions, engaging social events, and regular after-work gatherings.

Medincell is a pharmaceutical company dedicated to improving global health by developing innovative, long-acting injectable treatments. They focus on creating accessible and affordable therapies that address unmet medical needs, with a particular emphasis on improving treatment adherence and minimizing environmental impact. Their proprietary BEPO® technology platform enables the controlled release of active pharmaceutical ingredients, allowing for extended durations of action and potentially enhanced efficacy.

Medincell fosters a culture of entrepreneurial spirit, collaboration, and respect, prioritizing the well-being and growth of its employees. The company values direct communication, transparency, and adaptability, encouraging employees to challenge the status quo and embrace innovation. They promote a fun and engaging work environment with a strong emphasis on diversity, inclusion, and shared success, empowering employees to become shareholders and contribute to the company's mission of improving global health.

Medincell is committed to creating a diverse and inclusive workplace where all employees feel valued and respected. Their approach centers on fostering a dynamic and nurturing work environment that embraces the unique talents and perspectives of every team member. They actively promote employee share ownership to ensure equitable value sharing and encourage a collaborative atmosphere built on trust, respect, and transparency. Their commitment to diversity is reflected in their multicultural workforce, representing 25 nationalities, and their high score on the “Égalité Femmes-Hommes” index, indicating their dedication to gender equality.